PONTELAND MEDICAL GROUP
MEADOWFIELD, PONTELAND, NEWCASTLE UPON TYNE
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 15 | 16 | 93.8% | |
| HF 4 | 2011 | 20 | 23 | 87.0% | |
| HF 4 | 2012 | 20 | 22 | 90.9% | |
| HF 4 | 2013 | 20 | 25 | 80.0% | |
| HF004 | 2014 | 15 | 18 | 83.3% | |
| HF004 | 2015 | 15 | 18 | 83.3% | |
| HF004 | 2016 | 18 | 21 | 85.7% | |
| HF004 | 2017 | 21 | 23 | 91.3% | |
| HF004 | 2018 | 70 | 72 | 97.2% | |
| HF004 | 2019 | 62 | 65 | 95.4% | |
| HF004 | 2020 | 67 | 71 | 94.4% | |
| HF006 | 2021 | 74 | 78 | 94.9% | |
| HF006 | 2022 | 72 | 76 | 94.7% | |
| HF006 | 2023 | 72 | 74 | 97.3% |
